1. Home
  2. PROF vs EOD Comparison

PROF vs EOD Comparison

Compare PROF & EOD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Profound Medical Corp.

PROF

Profound Medical Corp.

HOLD

Current Price

$6.92

Market Cap

243.2M

Sector

Health Care

ML Signal

HOLD

Logo Allspring Global Dividend Opportunity Fund of Beneficial Interest

EOD

Allspring Global Dividend Opportunity Fund of Beneficial Interest

HOLD

Current Price

$6.53

Market Cap

271.7M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
PROF
EOD
Founded
N/A
2007
Country
Canada
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Investment Managers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
243.2M
271.7M
IPO Year
2017
N/A

Fundamental Metrics

Financial Performance
Metric
PROF
EOD
Price
$6.92
$6.53
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$12.00
N/A
AVG Volume (30 Days)
61.0K
87.1K
Earning Date
05-07-2026
01-01-0001
Dividend Yield
N/A
9.28%
EPS Growth
25.89
N/A
EPS
0.19
N/A
Revenue
$16,098,000.00
N/A
Revenue This Year
$92.40
N/A
Revenue Next Year
$64.10
N/A
P/E Ratio
$35.95
N/A
Revenue Growth
50.73
N/A
52 Week Low
$3.92
$5.14
52 Week High
$8.95
$6.59

Technical Indicators

Market Signals
Indicator
PROF
EOD
Relative Strength Index (RSI) 49.50 59.25
Support Level $5.81 $5.58
Resistance Level $7.07 $6.59
Average True Range (ATR) 0.42 0.11
MACD -0.05 -0.01
Stochastic Oscillator 19.09 74.36

Price Performance

Historical Comparison
PROF
EOD

About PROF Profound Medical Corp.

Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of AI-powered, MRI-guided, incision-free therapies for the ablation of diseased tissue. The company's flagship product, the TULSA-PRO system, combines real-time MRI, robotically-driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to ablate whole gland or physician defined region of malignant or benign prostate tissue. Its platform technologies combine imaging, robotic control, and ultrasound-based thermal ablation for the treatment of prostate conditions. The company generates revenue through the sale of capital equipment and recurring sales of single-use devices and related services used in patient treatments.

About EOD Allspring Global Dividend Opportunity Fund of Beneficial Interest

Allspring Global Dividend Opportunity Fund is a diversified closed-end management investment company. Its primary investment objective is to seek a high level of current income. The fund's secondary objective is the long-term growth of capital. The fund allocates its assets between two separate investment strategies or sleeves. Under normal market conditions, the fund allocates approximately 80% of its total assets to an equity sleeve comprised of common stocks.

Share on Social Networks: